Oncotarget

Meeting Reports:

Sixth BHD Symposium and First International Upstate Kidney Cancer Symposium: latest scientific and clinical discoveries

Gennady Bratslavsky _, Mark R. Woodford, Michael Daneshvar and Mehdi Mollapour

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:15292-15298. https://doi.org/10.18632/oncotarget.7733

Metrics: PDF 1053 views  |   HTML 3860 views  |   ?  


Abstract

Gennady Bratslavsky1,2, Mark R. Woodford1,2,3, Michael Daneshvar1,2, Mehdi Mollapour1,2,3

1 Department of Urology, SUNY Upstate Medical University, Syracuse, NY, USA

2 Cancer Research Institute, SUNY Upstate Medical University, Syracuse, NY, USA

3 Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, NY, USA

Correspondence to:

Mehdi Mollapour, email:

Gennady Bratslavsky, email:

Keywords: FLCN, Birt-Hogg-Dubé syndrome, renal cell carcinoma, clear cell renal cell carcinoma

Received: November 25, 2015 Accepted: January 29, 2016 Published: February 25, 2016

Abstract

The Sixth BHD Symposium and First International Upstate Kidney Cancer Symposium concluded in September 2015, in Syracuse, NY, USA. The program highlighted recent findings in a variety of areas, including drug development, therapeutics and surgical management of patients with BHD and multi-focal renal tumors, as well as multidisciplinary approaches for patients with localized, locally advanced and metastatic renal cell carcinoma.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 7733